Leuko (private company)
		See something wrong or missing? Let us know
	
Offices:Madrid, Boston
			
			
			Business model:B2B
			
			Leuko is developing PointCheck, a proprietary device to measure white blood cell levels non-invasively, which can enable improved clinical outcomes and reduced costs for immunosuppressed patients.
					Investors:
					
						
							we tracked 3 investors
						
					
				
				
					You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
					Investments 1.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Leuko
| Name | Criteria | |
|---|---|---|
|  | Galgus 65% | 
 | 
|  | Jutro Medical 65% | 
 | 
|  | MOV.AI 65% | 
 | 
|  | Recycleye 65% | 
 | 
|  | ToolSense 65% | 
 | 
|  | Universal Quantum 65% | 
 | 
|  | Valka 65% | 
 | 
|  | QphoX 65% | 
 | 
|  | Synox France 65% | 
 | 
|  | Molecule.one 65% | 
 | 
 Belgium
 Belgium Germany
 Germany Switzerland
 Switzerland Denmark
 Denmark Estonia
 Estonia Finland
 Finland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Sweden
 Sweden Ireland
 Ireland Italy
 Italy